Home NDC 71288-103 Bendamustine
Product NDC 71288-103
11-digit product format 712880103
Labeler code 71288
Product ID 71288-103_c4d02b46-b7dc-4c54-9f17-49f378437808
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Bendamustine HCl
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Meitheal Pharmaceuticals Inc.
Application ANDA211001
Marketing category ANDA
Marketing start 2023-06-05
Substance BENDAMUSTINE HYDROCHLORIDE
Active strength 100 mg/20mL
Pharmacologic classes Alkylating Activity [MoA], Alkylating Drug [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211001-001 BENDAMUSTINE HYDROCHLORIDE BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 A211001-002 BENDAMUSTINE HYDROCHLORIDE BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 46 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / INTRAVENOUS AP 2023-06-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A211001-001 BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A211001-002 BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL POWDER / IV (INFUSION) AP 2023-06-05 9b2671bbb829…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 46 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Bendamustine
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 981Y8SX18M Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1805001 Internal RxNorm lookup 1805007 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71288-103-20 Bendamustine 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 20 10 71288-103-20 Bendamustine 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71288-103 BENDAMUSTINE (BENDAMUSTINE HCL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BENDAMUSTINE (BENDAMUSTINE HCL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC.] 9 Current NDC, 2 package rows 20230608_40f6f58d-d9ac-4f65-9fc7-16984bf1f180.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 71288-103-20 71288010320 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-103-20) / 20 mL in 1 VIAL, SINGLE-DOSE 2023-06-05 No No Current